regn

Putting Biotech Stocks Under the Microscope – Barron's – Barrons.com

In 1996, fresh out Harvard, Rajiv Kaul went to work as an analyst covering biotechnology at Fidelity Investments. At the time, the sector was still considered a risky niche—the perfect project for the new guy. “Biotech was viewed like a lottery ticket,” says Kaul, 41. “It was something conventional investors shied away from.”
Where others saw uncertainty, Kaul saw possibility. After […]

August 10, 2013 Byunknown amgen, change, dividend, market, ratio, regn, street, yield Comments Off read more

Putting Biotech Stocks Under the Microscope – Barron's

In 1996, fresh out Harvard, Rajiv Kaul went to work as an analyst covering biotechnology at Fidelity Investments. At the time, the sector was still considered a risky niche—the perfect project for the new guy. “Biotech was viewed like a lottery ticket,” says Kaul, 41. “It was something conventional investors shied away from.”
Where others saw uncertainty, Kaul saw possibility. After […]

August 10, 2013 Byunknown amgen, biotechnology, delayed, dividend, employee, nasdaq, ratio, regn, short Comments Off read more

Putting Biotech Stocks Under the Microscope – Barron's – Barrons.com

Putting Biotech Stocks Under the Microscope – Barron's

US open: Two Fed officials back QE

US close: Stocks edge higher on low job claims data

US close: Stocks reach record highs

US midday: Stocks turn around ahead of Fed minutes

US open: Stocks lower as Cyprus crisis continues

US open: Apple and Google move lower

Europe close: Stocks rise on German confidence

US midday: Stocks tread water ahead of Alcoa